An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application (ADN-CO)

July 29, 2020 updated by: Institut Paoli-Calmettes

The aim of our study is to investigate the effect of providing patients access to their electronic medical records Via the IPC Connect Application on their A Survey will be proposed to all outpatients with a solid or hematologic malignancy who will attend an appointement at Institut Paoli Calmettes clinic.

Data will be collected during a 1-month period. The auto-questionnaire will be composed of 31 questions addressed to all patients, 17 questions will be specifically addressed to patients using IPC connect application and 7 questions will be addressed to patients who do not use the application.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

8000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All outpatients with an solid tumor or an hematologic malignancy who will attend Institut Paoli-Calmettes Outpatients clinic during 1 months

Description

Inclusion Criteria:

  • Man or woman, age> 18 Years
  • Solid tumor or hematologic malignancy
  • Patient attending an appointment at Institut Paoli Calmettes
  • Non-opposition

Exclusion Criteria:

  • emergency, Vulnerable person or unable to provide informed consent
  • First appointment at Institut Paoli Calmettes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Institut Paoli Calmettes Outpatients
Patients with a solid tumor or an hematologic malignancy who will attend an appointement at IPC Outpatients clinic
Self-completed questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of Patients Access to Their Electronic Medical Records Via the IPC Connect Application on patients anxiety level
Time Frame: 1 day
Anxiety level will be measured by the Hospital Anxiety and Depression scale
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gwenaelle Gravis, Institut Paoli-Calmettes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 5, 2020

Primary Completion (Anticipated)

December 5, 2020

Study Completion (Anticipated)

December 5, 2020

Study Registration Dates

First Submitted

July 29, 2020

First Submitted That Met QC Criteria

July 29, 2020

First Posted (Actual)

August 3, 2020

Study Record Updates

Last Update Posted (Actual)

August 3, 2020

Last Update Submitted That Met QC Criteria

July 29, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • ADN-CO-IPC 2020-004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Solid Tumor

Clinical Trials on Survey

Subscribe